Skip to main content
. 2021 Mar 3;11:5103. doi: 10.1038/s41598-021-84553-7

Table 2.

Baseline factors associated with best-corrected visual acuity improvement at 1 year in patients with diabetic macular oedema under anti-vascular endothelial growth factor therapy.

VA change at the 12th month
P-value Coefficient
Hypertension 0.001 0.209
Previous treatment 0.031 0.136
Baseline VA (LogMAR)  < 0.001 − 0.337
Baseline epiretinal membrane 0.048 0.123
Baseline subretinal fluid 0.001 − 0.209
Baseline HRF in the outer retina 0.037 − 0.007

VA visual acuity, HRF hyperreflective foci.